津膜科技(300334) - 2025 Q4 - 年度业绩预告
TMMTTMMT(SZ:300334)2026-01-30 09:42

Financial Performance Expectations - The company expects a net profit attributable to shareholders to be in the range of -29.5 million to -22 million CNY for the year 2025, compared to a profit of 11.05 million CNY in the same period last year[4]. - The net profit after deducting non-recurring gains and losses is projected to be between -48 million and -40.5 million CNY, a significant decline from -21.98 million CNY in the previous year[4]. - The company anticipates non-recurring gains and losses for the period to be between 16 million and 21 million CNY, a substantial decrease from 33.02 million CNY in the previous year[7]. Operational Challenges and Strategies - Increased operating expenses due to organizational restructuring and historical receivables cleanup have contributed to the expected losses[6]. - The company is actively addressing current challenges by accelerating the implementation of existing orders and expanding market reach in key areas[8]. - The company aims to optimize operational management efficiency to lay a solid foundation for long-term development and gradually improve business performance[8]. Financial Reporting and Audit - The financial data in the earnings forecast has not been audited by registered accountants, but there are no significant discrepancies with the auditing firm[5]. - The earnings forecast data is based on preliminary estimates by the company's finance department, with detailed financial data to be disclosed in the 2025 annual report[8]. Investment Risks - Investors are advised to be aware of investment risks associated with the company's performance outlook[8]. Revenue Recognition - The company has seen a good growth in new contracts signed, but revenue recognition and gross profit from major projects have not yet been realized due to ongoing implementation[6].

TMMT-津膜科技(300334) - 2025 Q4 - 年度业绩预告 - Reportify